Skip to main content
2025 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Sarah Hersey, MS, MBA, RAC (she/her/hers)

Vice President, Head of Precision Medicine, Bioanalytical and Translational Sciences
Bristol Myers Squibb
Madison, New Jersey

Sarah is currently the Vice President, of Precision Medicine, Bioanalytical & Translational Sciences for Bristol Myers Squibb. She has more than 25 years of industry experience in leading R&D organizations, CLIA and GLP laboratories, bioanalytics, device manufacturing, consortiums, assessment and implementation of technology strategies, and development of in vitro diagnostics. Prior to joining BMS, Sarah was the Vice President, Precision Medicine & Companion Diagnostics for Celgene, where she founded their Precision Medicine Organization in 2016. She joined Celgene after having held the position as the Global Head of Future Precision Medicine for Novartis. Sarah has also held multiple roles with increasing responsibility within Johnson and Johnson (JNJ) including Global Head of Operations, Assay Program Leader for Companion Diagnostics Center of Excellence, Director of Materials Process Development and Enabling Technologies.

Disclosure information not submitted.

Presentation(s):